Radius Health Cmn (NASDAQ:RDUS).
Raymond James & Associates says it sold 27,627 shares in the previous quarter decreasing its stake in Radius Health Cmn (RDUS) by 72.4%. Its position was valued at $406,000 a decrease of 72.5% according to the filing.
The following firms have recently changed their position in RDUS. Ubs Asset Management Americas Inc augmented its stake by buying 839 shares an increase of 14.2% as of 09/30/2017. Ubs Asset Management Americas Inc controls 6,765 shares worth $260,791,000. The total value of its holdings decreased 2.7%. As of quarter end Bb Biotech Ag had acquired 460,000 shares growing its stake by 9.1%. The value in dollars decreased from $227,905,000 to $211,979,000 decreasing 7.0% since the last quarter.
As of the end of the quarter Alliancebernstein L.P. had bought a total of 22,493 shares growing its position 6.5%. The value of the company’s investment in Radius Health Cmn went from $15,627,000 to $14,186,000 a change of $1,441,000 quarter to quarter.
Jefferies Group LLC lowered the price target on November 3 cutting the projection from $38.00 to $31.00 and stated a “Hold” rating. On November 3 Cantor Fitzgerald maintained a stock rating of “Buy” projecting a price of $58.00.
October 6 investment analysts at Goldman Sachs Group, Inc. (The) made no change to the stock rating of “Neutral” with a current price target of $45.00. September 29 investment analysts at Maxim Group maintained a “Positive” rating on the company.
On August 9 Jefferies Group LLC left the company rating at “Hold” targeting a price of $38.00. On July 31 analysts at Canaccord Genuity updated guidance on RDUS with a rating of “Buy” and establishing a price target of $85.00.
In the market the company is trading down by 0.30% percent from yesterday’s close. The company currently has a P/E ratio of N/A and the market value is 1.17B. As of the last earnings report the EPS was $-5.43 with 44.59M shares outstanding.
Investors are a little more bearish on Radius Health Cmn of late if you pay attention to the rise in short interest. The stock saw a rise in short interest of 5.64% between September 29, 2017 and October 13, 2017. Short shares increased from 9,792,339 to 10,344,895 over that period. With short interest at 10,344,895 and short average daily volume at 678,294, days to cover is 15.0 and the percentage of shorted shares was 0.23% on October 13.